Pontifax Management 4 GP (2015) Ltd. 13D and 13G filings for Nuvectis Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-05 10:55 am Sale |
2024-09-30 | 13G | Nuvectis Pharma, Inc. NVCT |
Pontifax Management 4 GP (2015) Ltd. | 288,873 1.500% |
-628,527 (-68.51%) |
Filing |
| 2024-02-06 08:47 am Purchase |
2023-12-31 | 13G | Nuvectis Pharma, Inc. NVCT |
Pontifax Management 4 GP (2015) Ltd. | 917,400 5.300% |
917,400 (New Position) |
Filing |